4th Quarter - Report

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for PHARMATHENE

Period 4th Quarter 2011 Filed Jan 20, 2012 Signed by Christine M. Warnke, Senior Governmental Affairs Advisor

Official filing
Firm
HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
Client
PHARMATHENE
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2012 Labor, HHS Appropriations, S 1599FY H3070; Consolidated Appropriations Act, 2012; HR 2055, H3671 (PL 112-74); Consolidated and Further Continuing Appropriations Act 2012, H 2112; Temporary Payroll Tax Cut Continuing Act of 2011; H 3630, Budget Control Act of 2011, S 365, PL 112-25.

LobbyistCovered position, as disclosed
CHRISTINE M WARNKE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2055 (112th)

Medical/Disease Research/Clinical Labs MED

HR 2405, Pandemic All-Hazard Preparedness Reauthorization Act.S 1855.

LobbyistCovered position, as disclosed
CHRISTINE M WARNKE —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2405 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.